Source – Pregabalin prescribing patterns in Australian general practice, 2012–2018: a cross-sectional study[/caption]
National Medicines Symposium 2024 speakers (L to R): Steve Waller, Professor Jennifer Martin, Professor Libby Roughead, Tegan Taylor[/caption]
This CPD activity is sponsored by Reckitt. All content is the true, accurate and independent opinion of the speakers and the views expressed are entirely their own.[/caption]
HPV vaccine – protective and no riskier than placebo
HPV vaccine protects against cervical precancer in female adolescents and does not increase the risk of serious adverse effects.
This is the finding of Cochrane...
Royal Pharmaceutical Society director on the future of pharmacy
Ravi Sharma’s credentials in pharmacy are formidable. Recently appointed the Royal Pharmaceutical Society’s (RPS’s) director for England, he was also National Clinical Lead for...
Kieran Baker extended interview
Pharmacists are generally resistant to working with the aged care sector. It requires around-the-clock attention to detail and on-call availability with a growing list...
Catastrophic fire ratings highlight need for better emergency dispensing provisions
State and federal health departments have advised of options available to pharmacists in parts of NSW and Queensland affected by this week’s catastrophic-level fires.
Under...
Indirect impacts of COVID-19
Australia has had relative success in suppressing the COVID-19 virus, but there continues to be myriad ongoing and wide ranging indirect impacts.
Remote Australians at increased risk for diabetes complications
Mortality rates are four times higher for Indigenous patients with diabetes than non-Indigenous Australians, a report has found.
The Australian Institute of Health and Welfare...
